NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Devices · USD

Apyx Medical Corporation (APYX) Stock Analysis

Apyx Medical Corporation (APYX) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

APYX

$3.05

−$0.01 (−0.33%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare APYX with… →

APYX Key Statistics

As of Sep 4, 2026
Trading
Open
$3.06
Previous Close
$3.06
Day's Range
3.02–3.08
52-Week Range
1.70–5.08
Volume
62.10K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.31
Valuation
Market Cap
$128.48M
P/E Ratio
unprofitable
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
0.59
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
2.20
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.20
Financials (FY)
Revenue (FY)
$52.84M+9.86%
Net Income (FY)
−$11.21M
Profit marginThe share of revenue left as profit after all costs and taxes.
−14.78%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
42.12M
1-Year Return
+48.78%
Dividend and dates
Earnings Date
November 5, 2026estimated
Avg Volume
124.99K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

APYX Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−12.86%
2025+121.52%
2024−39.69%
2023+11.97%
2022−81.75%
2021+78.06%
2020−14.89%
2019+30.76%

As of September 4, 2026.

APYX Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$52.84M−$11.21M−21.2%
2024$48.10M−$23.46M−48.8%
2023$52.35M−$18.71M−35.7%
2022$44.51M−$23.18M−52.1%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$52.84M$33.04M−$6.45M−$11.21M−21.2%
2024$48.10M$29.36M−$18.85M−$23.46M−48.8%
2023$52.35M$33.76M−$19.95M−$18.71M−35.7%
2022$44.51M$29.13M−$23.56M−$23.18M−52.1%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

APYX Valuation vs Medical Devices Median

Median of 151 stocks
MetricAPYXMedical Devices medianvs median
P/S ratio2.202.9826% below
Profit margin−14.78%−1.69%13.1 pts below

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Apyx Medical Corporation (APYX) at $128.48M. It is classified in the Medical Devices industry, within the Healthcare sector. The company reports 205 employees.

Over the past 52 weeks the price has ranged from $1.70 to $5.08. The most recent close on file for APYX is $3.05, dated September 4, 2026. That is −$0.01 (−0.33%) against the previous close. The latest close sits 79.41% above that 52-week low.

Financial Health

In fiscal 2025, Apyx Medical Corporation reported revenue of $52.84M. Against the prior fiscal year total of $48.10M, that is a change of +9.86%. The same year closed with a net loss of $11.21M. The reported profit margin is −14.78%. That is 13.1 percentage points below the Medical Devices median of −1.69%. Trailing earnings per share are −0.2.

Across the 4 fiscal years on file, revenue moves from $44.51M in 2022 to $52.84M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. The PEG ratio, which sets the P/E against expected earnings growth, reads 0.59. The price-to-sales ratio is 2.2. On price-to-sales that is 26.1% below the Medical Devices median of 2.98. The medians here are taken across 151 Medical Devices companies that report the metric.

Over the trailing twelve months the price has returned +48.78%. Measured over 5 years, that is −23.02% a year compounded. Beta against the wider market is reported at 1.31. Daily returns over the trailing 7 years annualize to a volatility of 93.03%.

Growth & Income

No dividend is on file for APYX.

2026 is still running; the price is −12.86% year to date. The strongest complete calendar year on file is 2025 at +121.52%; the weakest is 2022 at −81.75%. Of the 7 complete calendar years on file, 4 finished higher.

Peer Comparison

Apyx Medical Corporation (APYX) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Apyx Medical Corporation APYX $128.48M —
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. Apyx Medical Corporation has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

 MDT

Medtronic plc.

$120.46B

 SYK

Stryker Corporation

$116.27B

 BSX

Boston Scientific Corporation

$69.27B

 EW

Edwards Lifesciences Corporation

$51.82B

 DXCM

DexCom, Inc.

$33.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Apyx Medical Corporation

Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company's helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Visit website →